ASX:DXB Dimerix (DXB) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Dimerix Stock (ASX:DXB) 30 days 90 days 365 days Advanced Chart Get Dimerix alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationA$282.11 millionP/E RatioN/ADividend Yield5.16%Price TargetN/AConsensus RatingN/A Company Overview Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. The company develops DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 which is in phase 2 clinical trial for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for chronic obstructive pulmonary disease, as well as develops proprietary receptor- HIT assay technology. Dimerix Limited is headquartered in Fitzroy, Australia. Read More Receive DXB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dimerix and its competitors with MarketBeat's FREE daily newsletter. Email Address DXB Stock News HeadlinesDimerix Limited Announces Director’s Interest ChangeJuly 7, 2025 | tipranks.comDimerix Limited Seeks Quotation for New Securities on ASXJuly 1, 2025 | tipranks.comI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.July 13 at 2:00 AM | Porter & Company (Ad)Health Check: Tetratherix breaks biotech IPO drought with 13pc gain on debutJune 29, 2025 | msn.comDimerix Limited Seeks ASX Quotation for New SecuritiesJune 27, 2025 | tipranks.comDimerix Limited Announces Quotation of New Securities on ASXJune 23, 2025 | tipranks.comDimerix Director Adjusts Holdings with Options ExerciseJune 22, 2025 | tipranks.comDimerix Limited Issues New Securities to Bolster Market PositionJune 19, 2025 | tipranks.comSee More Headlines DXB Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Dimerix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dimerix investors own include IMMURON (IMRN), Noxopharm (NOX), Tabcorp (TAH), NexGen Energy (NXE) and Novogen (KZIA). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:DXB CIKN/A Webdimerix.com Phone1.212.250.8024FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$17.08 million Net Margins-2,926.43% Pretax MarginN/A Return on Equity-171.59% Return on Assets-42.83% Debt Debt-to-Equity Ratio0.82 Current Ratio9.49 Quick Ratio7.91 Sales & Book Value Annual SalesA$9.12 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.04 per share Price / BookN/AMiscellaneous Outstanding Shares557,130,000Free FloatN/AMarket CapA$282.11 million OptionableNot Optionable Beta0.53 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (ASX:DXB) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dimerix Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.